Metraipolis › archive › dc_346150d2842e
Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41030857
- DOI
- 10.3389/fendo.2025.1654506
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:04:37.355Z
- SHA-256 of the archived text
5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400- Stable URL of this page
https://metraipolis.com/documento/dc_346150d2842e
How to cite
Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857 — Europe PMC (en), https://europepmc.org/article/MED/41030857 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_346150d2842e (Metraipolis archive dc_346150d2842e, sha256 5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400)
BibTeX
@misc{dc346150d2842e,
title = {Case Report: Efficacy and safety of dose-escalated Mazdutide, a GLP-1/GCGR dual agonist, in an adolescent with obesity, type 2 diabetes, and hyperuricemia — Europe PMC PMID:41030857},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41030857},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_346150d2842e; sha256 5f5e3884c9e3896844e163c5a1f0289ccc719763199732b5820635e04334a400},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41030857. Agents can read the archived copy with the MCP tool read_document.